Nash UNC HealthCare

Rocky Mount, North Carolina 27804

1 studies enrolling now · 6 studies all time

What they study most

COVID-19 Infection, Chemotherapy-Induced Peripheral Neuropathy, HER2/Neu Positive, Hematopoietic and Lymphatic System Neoplasm, Hematopoietic and Lymphoid Cell Neoplasm, Male Breast Carcinoma, Malignant Solid Neoplasm, Metastatic Breast Adenocarcinoma, Metastatic HER2-Positive Breast Carcinoma, Metastatic Malignant Solid Neoplasm, Progesterone Receptor Positive, Recurrent Breast Adenocarcinoma

Studies at this site

• Vitamin D for Prostate Endocrine Therapy — Recruiting now
• NCI COVID-19 in Cancer Patients, NCCAPS Study — Running, not enrolling
• Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed by Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery — Completed
• Testing the Drug Atezolizumab or Placebo With Usual Therapy in First-Line HER2-Positive Metastatic Breast Cancer — Stopped early
• Testing the Effects of Exercise on Chemotherapy-Induced Peripheral Neuropathy — Running, not enrolling
• Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer — Completed